Cardiometabolic outcomes up to 12 months after COVID-19 infection. A matched cohort study in the UK.
<h4>Background</h4>Acute Coronavirus Disease 2019 (COVID-19) has been associated with new-onset cardiovascular disease (CVD) and diabetes mellitus (DM), but it is not known whether COVID-19 has long-term impacts on cardiometabolic outcomes. This study aimed to determine whether the incid...
Main Authors: | Emma Rezel-Potts, Abdel Douiri, Xiaohui Sun, Phillip J Chowienczyk, Ajay M Shah, Martin C Gulliford |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2022-07-01
|
Series: | PLoS Medicine |
Online Access: | https://doi.org/10.1371/journal.pmed.1004052 |
Similar Items
-
Cardiometabolic outcomes up to 12 months after COVID-19 infection. A matched cohort study in the UK
by: Emma Rezel-Potts, et al.
Published: (2022-07-01) -
The effects of anti-depressants on depression symptom scores at 12 months follow-up in patients with cardiometabolic disease: Results from a large primary care cohort
by: Bhautesh Dinesh Jani, et al.
Published: (2015-01-01) -
Dairy consumption and cardiometabolic health: outcomes of a 12-month crossover trial
by: Crichton Georgina E, et al.
Published: (2012-03-01) -
The impact of bariatric surgery procedures on the modulation of cardiometabolic risk factors in patients with severe obesity: a 12-month follow-up
by: Mastaneh Rajabian Tabesh, et al.
Published: (2022-10-01) -
Risk of cardiometabolic outcomes among women with a history of pelvic inflammatory disease: a retrospective matched cohort study from the UK
by: Kelvin Okoth, et al.
Published: (2023-02-01)